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Abstract In vitro, pancreatic β-cells tend to reduce their
ability to aggregate into islets and lose insulin-producing
ability, likely due to insufﬁcient cell–cell and cell–matrix
interactions that are essential for β-cell retention, viability
and functionality. In response to these needs, surfaces of
succinylated chitosan-based beads (NSC) were modiﬁed
with zwitterionic carboxy-betaine (CB) moieties, a compa-
tible osmolyte known to regulate cellular hydration state,
and used to promote the formation of β-cell spheroids using
a conventional 2D cell culture technique. The NSC were
synthesised by ionic gelation and surface-functionalised
with CB using carbodiimide chemistry. Scanning electron
microscopy (SEM), dynamic laser scattering (DLS) and
Fourier transform infrared spectroscopy (FTIR) were
employed as characterisation tools to conﬁrm the successful
modiﬁcation of the succinylated chitosan material into
spherical beads with rough surfaces and a diameter of 0.4
µm. NSC with and without CB were re-suspended at con-
centrations of 0.1, 0.3 and 0.6 mg/mL in saline medium and
tested in vitro with MIN6 murine pancreatic β-cell line.
Results showed that a concentration of 0.3 mg/mL, NSC-
CB encouraged pancreatic MIN6 cells to proliferate and
form spheroids via E-cadherin and Pdx-1 activation within
48 h in culture. These spheroids, with a size of approxi-
mately 80 µm, exhibited high cell viability and enhanced
insulin protein expression and secretion when compared to
cells organised by the non-modiﬁed beads.
1 Introduction
Pancreatic islets, also known as Langerhans islets, are
spherical units that are comprised of clusters of cells dis-
tributed throughout the pancreas [1]. The β-cells are one of
the major cell types within islets and are involved in storing
and releasing insulin, a hormone that is critical in the reg-
ulation of blood glucose levels [2]. β-cell activities are
tightly controlled by neighbouring cells and the extra-
cellular matrix (ECM) that closely interact with β-cells
through cell surface proteins (e.g. E-cadherin) and gap-
junctions [3]. Direct contacts between cell–cell and
cell–matrix are therefore essential to maintain the survival
and function of β-cells [4]. During in vitro cell culture, β-
cells are isolated from their native tissues and grow on
traditional tissue culture plates coated with non-adhesive
substances (e.g. agarose) or roller ﬂasks and shakers. These
current techniques have been shown to disrupt both
cell–cell and cell–matrix interactions by inducing changes
in gene expression and β-cell phenotype. Progress in the
development of three dimensional (3D) culture methods has
addressed these limitations [5] through the use of bio-
compatible materials for microencapsulation or layer-by-
layer coating of single islets [6] that are capable of
mimicking the natural cellular microenvironment and
enhancing β-cell activities [7]. For example, pancreatic
MIN6 cells demonstrated a better survival rate and glucose
responsiveness to insulin over a ten day incubation when
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they were encapsulated in cell adhesive peptide (RGD)-
modifed PEG hydrogels [8]. However, even the most
advanced in vitro 3D culture approaches lack important
features needed to reconstitute the in vivo β-cell micro-
environment [9, 10]. Particle-based materials, especially
beads, have attracted some interest for many technological
applications and shown varying degrees of success as cul-
ture systems [11]. These materials offer advantages such as
high tissue permeability [12], lower enzymatic degradation
[13] and large surface area [14]. To date, beads have
commonly been prepared using natural polymers, such as
chitosan, a polysaccharide that possesses excellent biode-
gradable, bioadhesive and biocompatible properties [15].
Chitosan is a naturally occurring biopolymer produced
on an industrial scale for use in the pharmaceutical, cos-
metics, agriculture and food sectors [16]. It is derived from
the deacetylation of chitin, a major by-product of the marine
and ﬁshery industry, to different degrees by reaction with
strong alkali. Deacetylation of chitin forms β-(1→4)-linked
2-amino-2-deoxy-D-glucopyranose (GlcN, D-unit) and 2-
acetamido-2-deoxy-D-glucopyranose (GlcAc, A-unit) units
in chitosan, the ratio of which can be measured using NMR
to yield the degree of deactylation as a percentage (% DD).
The removal of acetyl groups results in the presence of free
amino functionalities in chitosan, and is responsible for its
polycationic nature in acidic solutions [17]. However, the
poor solubility of unmodiﬁed chitosan in both water and
organic solvents has strictly limited its ﬁnal application
[18]. This limitation has been overcome using N-succinyl-
chitosan (SNC) an acyl derivate of chitosan that is prepared
by introducing succinyl groups onto the N-terminals of the
chitosan glucosamine units [19]. As such, NSC presents
favourable properties such as good biocompatibility and
low toxicity, but it still faces problems with regards to
biomolecular recognition.
Recently, aqueous solutions of carboxy-betaine (CB)
derivatives, which are known to be zwitterionic materials,
have drawn special attention due to their anti-biofouling
properties of resisting protein adsorption and bioﬁlm for-
mation on a variety of substrates and surfaces as well as
providing the capability for further biomaterial functiona-
lisation [20]. Also conferring protection to the cells against
environmental stresses like osmotic irregularity, adverse
temperatures, and dehydration [21], CB is considered a
promising therapeutic agent in the treatment of a number of
diseases including Alzheimer [22], hepatopathy [23] and
cancer [24]. The overall hydration property of CB is
probably related to its capacity to form hydrogen-bonded
interactions with a range of organic and inorganic acids
owing to a high electron density on its two carboxylic
oxygen atoms. This is responsible for both the structure and
properties of CB and has been shown to greatly support cell
adhesion and proliferation in several types of cells [25]. In
this study, betaine-modiﬁed NSC-beads (NSC-CB) were
considered to have the potential to act as a simple innova-
tive in vitro cultivation system for the aggregation and
formation of MIN6 cell spheroids without the use of com-
plex equipment including rotary shaker, hanging-drop plate
and artiﬁcial matrix. Therefore, NSC-based beads have been
created and assessed for their potential to (i) be easily
modiﬁed with CB molecules; (ii) act as a scaffold system to
encourage formation of pancreatic β-cell (MIN-6) spheroids
under 2D culture conditions and (iii) control metabolic
functionality including the storage and release of insulin by
the MIN6 cells via E-cadherin and Pdx-1.
2 Materials and methods
2.1 Synthesis and functionalisation of N-succinylated
chitosan beads
Chitosan (Aldrich-Sigma, UK) was dissolved in acetic acid
and diluted 1:1 with methanol before derivatisation with 4%
(w/v) succinic anhydride in acetone solution (SC) (Fischer
Scientiﬁc, UK). Ionic gelation at a 4:1 volume ratio with 1
mg/mL sodium tripolyphosphate (NaTPP) (Aldrich-Sigma,
UK) in deionised H2O was used to form N-succinylated
chitosan beads (NSC). The surface was tethered with
betaine (CB) (Aldrich-Sigma, UK) by previous activation of
the relevant functional groups with 10× molar excess N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide hydro-chloride
(EDC) and a 25× molar excess N-hydroxysuccinimide
(NHS) in 0.1 M MES buffer pH 6.0 (Aldrich-Sigma, UK).
NSC-CB were desalted into deionised H2O using dialysis
with 3.5 kDaMW cut off cellulose tubing and ﬁltered
through a 0.45µm-pore syringe before lyophilisation.
2.2 Characterisation analysis of NSC with and without
CB
Fourier transform infrared spectroscopy (FTIR) was carried
out using a Perkin Elmer Spectrum 65 and used to conﬁrm
both the N-succinylation of the chitosan and its functiona-
lisation with CB; whereas both morphology and structure of
NSC and NSC-CB were investigated using a Zeiss Σigma™
ﬁeld emission gun scanning transmission electron micro-
scope (SEM, FEG-STEM). The size of the beads was
evaluated using a dynamic light scattering system (DLS)
from Zetasizer ZS90 (Malvern Instruments Ltd., UK).
2.3 Cell culture and seeding
The mouse pancreatic β MIN6 cells were maintained in
low-glucose Dulbecco’s modiﬁed Eagles’s medium
(DMEM, Gibco® Life Technologies Ltd., UK)
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supplemented with 10% v/v foetal bovine serum (FBS,
Aldrich-Sigma, UK) in an incubator at 37 °C and 5% CO2
for 1 complete passage before use in experiments.
MIN6 cells (passage 32) were seeded at an optimal
density of 4× 104/mL [26] and cultured with both NSC and
NSC-CB at concentrations of 0.1, 0.3, and 0.6 mg/mL
according to a patented method [27] for 48 h incubation.
Cells seeded on tissue culture grade polystyrene plates
(TCP) were used as a traditional 2D negative control; while
a positive control of 3-D spheroid formation was achieved
by seeding MIN6 cells on commercial Matrigel substrates
(BDBioscience, UK), known to induce cell aggregation
[28].
2.4 Morphology and morphometric analysis of MIN6
cells
MIN6 cells treated with NSC and NSC-CB were imaged
using phase contrast microscopy (Leica DM2500) with an
×10 magniﬁcation connected to a digital camera (Canone
LM Scope) within 48 h incubation. The size of each
spheroid was determined using ImageJ software (ImageJ,
1.42q, National Institutes of Health, NHI) and expressed as
mean diameter± standard deviation (n= 12).
2.5 Cell viability and toxicity
To identify both live and dead cells, MIN6 cells were
stained with 50 µl of Hoesch-Propidium Iodide (HPI, Sigma
Aldrich, UK) (ratio 1:1) and imaged using a 10× objective
lens attached to an epi-ﬂuorescence Zeiss Axiovert 25 UV
microscope 48 h after plating. Fluorescence of the tested
cells was quantiﬁed using an established protocol [29] while
data were expressed as percentage of either viable and
apoptotic cells (n= 12).
The supernatants from each sample were collected and
analysed using a cytotoxicity assay kit based on LDH
release (Promega, UK). Brieﬂy, a 1:1 ratio of sample was
mixed with LDH substrate (provided in the kit), and incu-
bated for 30 min at room temperature protected from light.
The enzyme reaction was then stopped by adding an equal
volume of 1M acetic acid, with absorbance measured in
triplicate at 492 nm with spectrophotometer (ThermoAskin
Accent, UK).
2.6 Immunoﬂuorescent staining of MIN6 cells
MIN6 cells were ﬁxed in chilled methanol for 15 min at 20 °
C, rinsed with phosphate-buffered saline (PBS), and
blocked with bovine serum albumin (BSA; Sigma Aldrich,
UK) to prevent nonspeciﬁc staining. The cells were incu-
bated in a polyclonal insulin primary antibody (1:75, Cell
Signalling, UK) and a mouse monoclonal antibody against
E-cadherin (1:100; AbCam, UK) overnight at 4 °C. They
were then rinsed in PBS and immunolabelled with sec-
ondary antibodies (Alexa Fluor 488 anti-rabbit IgG and
Alexa Fluor 488 anti-rat IgG, 10 μg/mL; Invitrogen, UK) in
the dark at room temperature for 1 h. The stained cells were
washed again, incubated in 11 μM 4′-6-diamidino-2-phe-
nylindole (DAPI, Invitrogen, UK) to counterstain the nuclei
and imaged using a Leica TCS SP5 laser scanning confocal
microscope with an objective lens ×20. E-cadherin reg-
ulation was then evaluated using a feature of ImageJ,
Regions of Interests (ROI) Manager (http://mirror.imagej.
net), and expressed as means ± standard deviation of
ﬂuorescent E-cadherin expressing cells (n= 12).
2.7 Insulin secretion
Insulin concentration in the supernatants collected from the
cell culture study was assessed using an anti-mouse insulin
ELISA kit (Millipore, UK). The method followed manu-
facturer instructions as stated for cell supernatant samples.
The absorbance was read at 450 nm by a spectrophotometer
plate reader (Biotek ELx800, UK) at 450 nm (n= 6);
whereas insulin values were normalised against the total
protein content (Bradford assay, Bio-rad, UK) and expres-
sed as ng/mg of protein for each sample (n= 6).
2.8 Western blotting
MIN6 cells were detached with 0.02 % EDTA and prepared
for protein extraction using a solution of lysis RIPA buffer
supplemented with 50 µg/mL protease inhibitors (Aldrich-
Sigma, UK). The total protein content was then measured
by the Bradford assay while their equivalent amounts (30
µg) were separated by sodium dodecyl sulfate (SDS)-gel
electrophoresis on 10% polyacrylamide gel (Biorad, UK)
and blotted against a nitrocellulose membrane (Amersham,
UK) at a constant current of 20 mA overnight. Membranes
were blocked with 0.01% w/v BSA in a Tris-buffered saline
(TBS)-Tween solution (TBST, 0.5 M Trizma, 1.5 M NaCl
and 0.2 % Tween-20, pH 7.4) and then incubated with
speciﬁc primary antibodies including anti-Ki67, and anti-
Pdx-1 (1:100; Abcam, UK) overnight at 4 °C. After being
washed with TBST three times, membranes were treated
with appropriate HRP-conjugated secondary antibodies
(1:1000; Invitrogen, UK) for 1 h at room temperature and
developed using an ECL detection kit according to the
manufacturer’s instructions (Amersham, UK). GAPDH was
used as a positive control.
2.9 Statistical analysis
Statistical analysis was carried out using ANOVA test while
quantitative data were expressed as mean± standard
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deviation. A level of signiﬁcance of p ≤ 0.05 was regarded
as statistically signiﬁcant.
3 Results
3.1 Characterisation and analysis of NSC with and
without CB
The successful succinylation of the chitosan was conﬁrmed
by FTIR (Fig. 1a). In NSC absorption bands were visible at
2924 cm−1 (stretching of –CH2-), 3268 and 1062 cm
−1
(amino group characteristics), 1644 cm−1 (Amide I) and
1379 cm−1 (Amide III) consistent with previous studies
[30]. Compared to the NSC spectrum, NSC-CB showed
distinct absorption bands attributed to the reduction of the
peaks at 1564 and 1546 cm−1 (primary amine groups),
increase of peaks at 2901 and 2987 cm−1, observed only in
the CB spectrum, and presence of peaks between 1075 and
1230 cm−1 related to the aliphatic amine region [31]. Such
successful modiﬁcation was supported by changes in
structure and surface morphology as shown in Fig. 1b. NSC
appeared almost spherical shape with a smooth surface that
appeared rough once modiﬁed with CB. NSC-CB were seen
to be slightly bigger in size (421 ± 44 nm) when compared
with NSC (303 nm ± 117 nm) (Fig. 1c).
3.2 NSC-CB encourage MIN6 cells to spontaneously
aggregate and form spheroids
At 48 h incubation, MIN6 cells grown onto TCP spread and
appeared of regular shape compared to those treated with
NSC at all concentrations tested (Fig. 2). NSC-treated cells
failed to reach a completely conﬂuent state especially those
with NSC at 0.6 mg/mL concentrations which have been
observed to be entrapped by close-packed beads. In con-
trast, cells treated with NSC-CB at 0.1 mg/mL became
organised into larger monolayers that spontaneously
Fig. 1 Characterisation of NSC with and without CB. a FTIR; b SEM (scale bar is 1 µm) and c DLS analysis
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aggregated together to form 3D spheroids when in contact
with higher NSC-CB concentrations as observed in
Matrigel-treated MIN6 cells. However, 0.3 mg/mL NSC-
CB gave rise to larger and more compact spheroids com-
pared to 0.6 mg/mL concentrations where presence of
monolayer MIN6 cells were still visible. At 48 h, 0.3 mg/
mL NSC-CB formed larger aggregates that were pre-
dominantly restricted to the periphery of spheroids (white
arrows).
As suggested by the micrographs, Matrigel substrates
maintained MIN6 cell clusters in their spheroidal geometry
during a 12–48-h culture period; whereas NSC-CB at 0.3
mg/mL concentrations resulted in individual cells sponta-
neously assembling in tight and larger spheroids (Fig. 3a).
The size of these spheroids was found to be larger [77.03 ±
11.08 µm] than those cultured onto Matrigel substrates
[27.41 ± 2.07 µm] as shown in Fig. 3b.
3.3 NSC-CB reduce cytotoxic effects of NSC and
improve MIN6 cell proliferation
The measurement of HPI staining demonstrated that cell
viability was higher, with more than 99% within all tested
cells. However, these levels were lower in those treated with
NSC at 0.3 and 0.6 mg/mL concentrations (~30%) (Fig. 4a).
At these concentrations, a twofold increase in the percen-
tage of apoptotic cells was also found (~50%) when com-
pared with control substrates and NSC-CB at 0.1, 0.3 and
0.6 mg/mL (~10%) (Fig. 4b). These results were corrobo-
rated by LDH data where elevated levels of LDH were
released by NSC-treated monolayer cells at 0.3 and 0.6 mg/
mL when compared to NSC-CB of comparative con-
centrations and within the range of the control cells at 48 h
(Fig. 4c). However, MIN6 cells treated with both 0.3 and
0.6 mg/mL NSC-CB released slightly higher amounts of
LDH (~4%) than cells onto TCP (~2%) which was linked to
anoikis [30] rather than material toxicity as similar effects
were detected within MIN6 spheroids seeded onto Matrigel
substrates (~4%). The presence of dead cells at the centre of
the NSC-CB-treated spheroids at 0.3 and 0.6 mg/mL was
also revealed in Matrigel-forming spheroids (Supplemen-
tary Data Fig. 1). Interestingly, Ki-67 protein expression, a
marker for proliferation, demonstrated that MIN6 cells grew
at a higher rate when treated with NSC-CB and control
substrates rather than NSC at 0.1, 0.3 and 0.6 mg/mL after
48 h of incubation (Fig. 4d).
3.4 E-cadherin regulation is upregulated within MIN6
cells by NSC-CB
An enhanced presence of cell–cell junctions was demon-
strated by a greater expression of the intercellular binding
protein E-cadherin within MIN6 cells treated with NSC-CB
compared with those with NSC at higher concentrations
(Fig. 5a). This was evenly distributed throughout the cyto-
plasm of both individual MIN6 cells and spheroids, but
sharply declined to undetectable levels (CTCF was 1.5- to
2-fold decrease) within NSC-treating cells at 0.3 and 0.6
mg/mL, respectively (Fig. 5b).
Fig. 2 Morphological changes of MIN6 cells cultured in various NSC conditions after 48 h incubation. White arrows indicate the formation of
aggregates made by NSC-CB at 0.3 mg/mL. Scale bar is 100 µm
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3.5 NSC-CB-treated cell spheroids store and release
insulin while highly express Pdx-1
To test whether NSC with and without CB were able to
maintain insulin expression throughout aggregation and
spheroid formation, MIN6 cells were assessed for their
ability to store (Fig. 6a) and release insulin (Fig. 6b). It was
found that all MIN6 cells were positive for insulin content,
particularly those seeded with NSC-CB. A stronger signal
was detected in the cytoplasm of each spheroid after 48 h
in vitro culture. However, the levels of insulin secreted by
NSC-CB-treated MIN6 cells [0.1 mg/mL= 10.5± 1.2 ng/
mg; 0.3 mg/mL= 11.01± 0.02 ng/mg; 0.6 mg/mL= 9.14
± 1.5 ng/mg] were found to be similar of those of TCP
[10.7 ± 1.3 ng/mg] and Matrigel control [11.7 ± 1.2 ng/mg];
whereas NSC-treated cells demonstrated impaired insulin
secretion [0.1 mg/mL= 7.5± 1.3 ng/mg; 0.3 mg/mL= 7±
0.79 ng/mg; 0.6 mg/mL= 5.9± 1.08 ng/mg]. Western blot
analysis also displayed increased protein expression levels
of Pdx-1 within both control cells and those grown with
NSC-CB compared to NSC at all concentrations tested as
shown in Fig. 6c.
4 Discussion
The lack of truly representative in vitro models of the
pancreatic islet hinder the elucidation of the mechanisms
involved in the maintenance of their viability and function.
Pancreatic β-cells in particular are generally considered to
be a difﬁcult cell type to keep alive and active in vitro [32].
Within 48–72 h of culture, the cells usually lose their ability
to secrete insulin and to express critical transcription factors
(e.g. Pdx-1) [33]. Recent studies have demonstrated that
both cell–cell and cell–matrix interactions are key regulators
with the ability to induce or repress β-cell identity and
function and as such represent key features of the pancreatic
microenvironment [34]. In light of this, 3D cellular spheroid
systems have attracted much attention as the increased cell-
to-cell interactions in spheroids have been demonstrated to
enhance cell survival and functioning after transplantation
into the body [8, 35]. A number of different approaches
have been developed for the aggregation of cells into
spheroids [36], but all still face distinct disadvantages
including batch-to-batch variation, being relatively labour-
intensive and prohibitively costly (e.g. Matrigel).
This study has taken a novel, cost effective approach to
encourage the aggregation of β-cells using CB-
functionalised succinylated chitosan beads to form func-
tional β-cell spheroids using conventional 2D tissue culture
techniques. The rationale for this approach was driven by
the potential for the zwitterionic coating to allow interaction
with the cell membrane glycocalyx that helps cells to bind
with each other and to retain water while providing inter-
cellular adherences and elaboration of speciﬁc chemical
cues [36]. The MIN6 insulinoma cell line was used in this
study to demonstrate that NSC-CB had the ability to pro-
mote both cellular recruitment and the spontaneous forma-
tion of spheroids within 48 h of culture, negating the use of
complex equipment employed in previous attempts to pro-
duce pseudoislets in vitro [9]. Thus, the successful grafting
of CB onto the surface of NSC via simple carbodiimide
Fig. 3 Spheroid formation. a
Phase contrast images (scale bar
is 100 µm) and b size of
spheroids formed onto Matrigel
substrates and NSC-CB at 0.3
mg/mL. *P ≤ 0.01; mean± SD;
n= 12
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chemistry under mild conditions was shown to provide an
ideal matrix for the loading of these zwitterionic units to
supply carboxyl groups enabling bio-conjugation. However,
the zwitterionic properties of CB are known to be lost
during the crosslinking process that allows CB to be grafted
onto NSC surfaces [37]. Nonetheless, when re-suspended
with MIN6 cells in medium, NSC-CB at a concentration of
0.3 mg/mL encouraged the formation of cellular spheroids
that increased in size within 48 h culture. It is proposed that
following the initial rapid preparation of NSC-CB, the
decrease in intermolecular and intramolecular hydrogen
bonding becomes weaker, resulting in increased self-
aggregation of NSC-CB once mixed with the cells in
medium. Within 48 h of culture, these beads aggregated to
form larger constructs that tightly inﬂuenced the morphol-
ogy, viability and activities of the MIN6 cells. However, at
higher concentrations of the functionalised beads-treated
MIN6 cells were induced to become immature while
showing an irreversibly inhibited proliferation, possible due
to a decrease in net negative surface charges on the MIN6
cell membrane as previously reported [38, 39]; this in turn
likely led MIN6 cells to be more susceptible to apoptosis
and hence death. When grafted onto NSC surfaces, CB not
only improved cell survival, but also showed the capability
to stimulate cell-to-cell interactions at the same levels as
those observed when TCP and Matrigel substrates were
used.
However, only 0.3 mg/mL SCN-CB generated spheroids
with dimensions similar to those seen in a native islet (~80
µm) [40, 41]. Although the size of these spheroids was
variable, unlike those observed on Matrigel substrates, it
can be suggested that they resemble more closely the
Fig. 4 Detection of toxicity and cell proliferation of MIN6 cells
treated with NSC and NSC-CB at distinct concentrations after 48 h
incubation. Percentage of a viable cells, b apoptosis and c LDH (* P ≤
0.05, mean± SD compared TCP; n= 12); d western blotting analysis
of Ki-67 expression compared to a positive control, GAPDH
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distribution seen in vivo where β-cells migrate from islets of
distinct sizes, probably as a way of maximising their
exposure to blood vessels [42].
Moreover, 0.3 mg/mL NSC-CB-forming spheroids
formed and preserved higher levels of intracellular insulin
contents as an indicator of a physiologically-like β-cell
function after up to 48 h in culture. Although, their insulin
secretory response was found to be slightly higher to that
within MIN6 cells grown onto control substrates, these
levels of insulin were predicted and are known to be related
to the cell viability data. The lack of oxygen severely
inﬂuenced insulin release from cells conﬁned to the centre
of spheroids which are known to be more prone to hypoxia
and indeed apoptosis [43]. It was also notable that NSC-
CB-forming spheroids grew at the same rate as those cul-
tured onto Matrigel substrates, presumably as a result of the
enhanced cell-to cell and cell–matrix contacts.
The precise correlation between E-cadherin and insulin is
still uncertain, but highly E-cadherin expressing NSC-CB
treated MIN6 cell spheroids were shown in this study to
secrete more insulin than those cultured with NSC at
equivalent concentrations. The strongest expression of E-
cadherin was observed in the more central part of SNC-CB-
treated MIN6 cell spheroids corresponding to cells that
showed the highest levels of insulin activity. However,
downregulation of E-cadherin negatively affected insulin
secretion within monolayers cultured with higher con-
centrations of NSC suggesting that the loss of E-cadherin
led cells to be functionally inactive. Recent studies have
suggested a relationship between E-cadherin and insulin
production as a function of cell proliferation [44], which
may explain the results seen in this study. It appears that the
functional connection between cell growth and this signal-
ling pathway likely involves Pdx-1, a regulator of β-cell
differentiation and survival [45]. Evidence has been repor-
ted to suggest that reduced Pdx-1 expression induces
impaired insulin secretion which is commonly associated
with abnormal β-cell morphology and decreased cell growth
and differentiation [46]. In accordance with this, the
amounts of both Ki-67 and Pdx-1 differed within non-
mature MIN6 cells treated with 0.3 and 0.6 mg/mL NSC,
corresponding to their lower insulin activity. Hence, the
selective modiﬁcation of NSC with CB, both chemically
and topographically, appeared to be essential for the normal
cellular development and function of MIN6 cells. By con-
trolling the delicate balance between cell apoptosis and
maturation, 0.3 mg/mL NSC-CB drastically promoted pro-
liferation of MIN6 cells within spheroids by enhancing their
Fig. 5 Functional expression of
E-cadherin activated within
monolayer and spheroid-
forming MIN6 cells tested with
non-modiﬁed and modiﬁed
NSC. a Localisation of E-
cadherin is shown in green while
blue represents DAPI staining of
the nucleus (scale bar is 50 µm);
b E-cadherin expression was
quantiﬁed by measuring relative
ﬂuorescence unit (RFU) of the
immunostaining. *P ≤ 0.01,
mean± SD; n= 12 (color ﬁgure
online)
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cell-to-cell interactions with potential repercussions for
insulin secretion.
In conclusion, NSC-CB has proven to be a valuable
method for the rapid and spontaneous generation of func-
tional β-cell spheroids. Among a wide range of cell culture
systems, it provides a simple, fast, reproducible and cost-
effective tool for the production of viable and functional
spheroids resembling the in vivo features of a cellular
microenvironment. This novel approach provides a new
model for in vitro studies aiming to elucidate the cellular
and molecular dynamics involved in the initiation and
progression of diabetes and preliminary testing of new
therapeutics.
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